Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toronto Association for Erectile Dysfunction and Premature Ejaculation
NCT05052879Phase 3Not yet recruiting
- Sponsor
- EMS
- Start
- Jul 2024
- Primary completion
- May 2026
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) and premature ejaculation (PE) (2 arms), sponsored by EMS. Primary endpoint: Percentage of participants with treatment response at 8 weeks. Planned start Jul 2024; status: not yet recruiting.
02
Conditions
erectile dysfunction (ED)premature ejaculation (PE)
Beyond the preview
Go deeper on NCT05052879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05052879.